Recently, the use of spectral-domain optical coherence tomography has contributed to our understanding of retinal abnormalities in schizophrenia.
Brian Miller, MD, PhD, MPH
Information on minimum and maximum effective doses has great clinical utility, and new findings provide guidance.
A study examining the connection between substance-induced psychosis and subsequent diagnosis of schizophrenia or schizoaffective disorder provides key implications for treatment.
An important clinical conundrum in the diagnosis of new-onset psychosis is the role of neuroimaging to rule out medically or surgically treatable causes of illness.
New insights on the association between family history of type 2 diabetes and comorbid diabetes in patients with schizophrenia and other nonaffective psychoses.
Maternal viral infection during pregnancy is a risk factor for schizophrenia. But there has been relatively less research on the association between maternal bacterial infection during pregnancy and psychosis risk.
New findings underscore the potential role of maternal bacterial infections during pregnancy in the etiology of psychosis.
Memory impairments have been shown to compromise quality of life in patients with schizophrenia. Findings from a recent study show that insulin resistance may be an underlying cause of memory loss in this population.
As research continues to point to a connection between the immune system and schizophrenia, a study of innate immunity in patients with first episode psychosis and schizophrenia provides further insights into the potential mechanisms of this link.
TMS for TRS? Researchers analyzed data to identify all randomized-controlled trials of rTMS versus sham treatment in patients with hard-to-treat forms of schizophrenia. Here’s what they found.